784 Federal Register / Vol. 87, No. 4 / Thursday, January 6, 2022 / Notices 

1 50 U.S.C. 4558(c)(1). 

2 85 FR 18403 (Apr. 1, 2020). 

3 DHS Delegation 09052, Rev. 00.1 (Apr. 1, 2020); 

DHS Delegation Number 09052 Rev. 00 (Jan. 3, 

2017). 

4 85 FR 50035 (Aug. 17, 2020). The Attorney 

General, in consultation with the Chairman of the 

Federal Trade Commission, made the required 

finding that the purpose of the voluntary agreement 

may not reasonably be achieved through an 

agreement having less anticompetitive effects or 

without any voluntary agreement and published the 

finding in the Federal Register on the same day. 85 

FR 50049 (Aug. 17, 2020). 

5See 85 FR 78869 (Dec. 7, 2020). See also 85 FR 

79020 (Dec. 8, 2020). 

II Proposal Title: Optimized Dry Powder 

Formulation and Delivery for Inhaled 

Clofazimine (N01). 

Date: January 27, 2022. 

Time: 1:00 p.m. to 3:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3G31, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Cynthia L. De La Fuente, 

Ph.D., Scientific Review Officer, Scientific 

Review Program, Division of Extramural 

Activities, National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3G31, 

Rockville, MD 20852, 240–669–2740, 

delafuentecl@niaid.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: December 30, 2021. 

Tyeshia M. Roberson-Curtis, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–00008 Filed 1–5–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; HHS–NIH–CDC–SBIR PHS 

2022–1: Development of Diagnostics to 

Differentiate HIV Infection from Vaccine 

Induced Seropositivity (Topic 103). 

Date: February 2, 2022. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3G22B, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Kristina S. Wickham, 

Ph.D., Scientific Review Officer, Scientific 

Review Program, Division of Extramural 

Activities, National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3G22B, 

Rockville, MD 20852, 301–761–5390, 

kristina.wickham@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: December 30, 2021. 

Tyeshia M. Roberson-Curtis, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–00009 Filed 1–5–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

Federal Emergency Management 

Agency 

[Docket ID FEMA–2020–0016] 

Meetings To Implement Pandemic 

Response Voluntary Agreement Under 

Section 708 of the Defense Production 

Act 

AGENCY: Federal Emergency 

Management Agency, Department of 

Homeland Security. 

ACTION: Announcement of meetings. 

SUMMARY: The Federal Emergency 

Management Agency (FEMA) is holding 

a series of meetings, under the Plan of 

Action to Establish a National Strategy 

for the Coordination of National 

Multimodal Healthcare Supply Chains 

to Respond to COVID–19, to implement 

the Voluntary Agreement for the 

Manufacture and Distribution of Critical 

Healthcare Resources Necessary to 

Respond to a Pandemic. 

DATES:

• Wednesday, January 5, 2022, from 1 

p.m. to 3 p.m. Eastern Time (ET). 

• Wednesday, January 12, 2022, from 

1 p.m. to 3 p.m. ET. 

• Wednesday, January 19, 2022, from 

1 p.m. to 3 p.m. ET. 

• Wednesday, January 26, 2022, from 

1 p.m. to 3 p.m. ET. 

FOR FURTHER INFORMATION CONTACT: 

Robert Glenn, Office of Business, 

Industry, Infrastructure Integration, via 

email at OB3I@fema.dhs.gov or via 

phone at (202) 212–1666. 

SUPPLEMENTARY INFORMATION: Notice of 

these meetings is provided as required 

by section 708(h)(8) of the Defense 

Production Act (DPA), 50 U.S.C. 

4558(h)(8), and consistent with 44 CFR 

part 332. 

The DPA authorizes the making of 

‘‘voluntary agreements and plans of 

action’’ with representatives of industry, 

business, and other interests to help 

provide for the national defense.1 The 

President’s authority to facilitate 

voluntary agreements with respect to 

responding to the spread of COVID–19 

within the United States was delegated 

to the Secretary of Homeland Security 

in Executive Order 13911.2 The 

Secretary of Homeland Security further 

delegated this authority to the FEMA 

Administrator.3

On August 17, 2020, after the 

appropriate consultations with the 

Attorney General and the Chairman of 

the Federal Trade Commission, FEMA 

completed and published in the Federal 

Register a ‘‘Voluntary Agreement, 

Manufacture and Distribution of Critical 

Healthcare Resources Necessary to 

Respond to a Pandemic’’ (Voluntary 

Agreement).4 Unless terminated earlier, 

the Voluntary Agreement is effective 

until August 17, 2025, and may be 

extended subject to additional approval 

by the Attorney General after 

consultation with the Chairman of the 

Federal Trade Commission. The 

Agreement may be used to prepare for 

or respond to any pandemic, including 

COVID–19, during that time. 

On December 7, 2020, the first plan of 

action under the Voluntary 

Agreement—the Plan of Action to 

Establish a National Strategy for the 

Manufacture, Allocation, and 

Distribution of Personal Protective 

Equipment (PPE) to Respond to COVID– 

19 (PPE Plan of Action)—was finalized.5

The PPE Plan of Action established 

several sub-committees under the 

Voluntary Agreement, focusing on 

different aspects of the PPE Plan of 

Action. 

On May 24, 2021, four additional 

plans of action under the Voluntary 

Agreement—the Plan of Action to 

Establish a National Strategy for the 

Manufacture, Allocation, and 

Distribution of Diagnostic Test Kits and 

other Testing Components to respond to 

COVID–19, the Plan of Action to 


TKELLEY on DSK125TN23PROD with NOTICE 
Federal Register / Vol. 87, No. 4 / Thursday, January 6, 2022 / Notices 785 

6See 86 FR 27894 (May 24, 2021). See also 86 FR 

28851 (May 28, 2021). 

7See 86 FR 57444 (Oct. 15, 2021). 

8See 50 U.S.C. 4558(h)(7). 

9 ‘‘[T]he individual designated by the President in 

subsection (c)(2) [of section 708 of the DPA] to 

administer the voluntary agreement, or plan of 

action.’’ 50 U.S.C. 4558(h)(7). 

Establish a National Strategy for the 

Manufacture, Allocation, and 

Distribution of Drug Products, Drug 

Substances, and Associated Medical 

Devices to respond to COVID–19, the 

Plan of Action to Establish a National 

Strategy for the Manufacture, 

Allocation, and Distribution of Medical 

Devices to respond to COVID–19, and 

the Plan of Action to Establish a 

National Strategy for the Manufacture, 

Allocation, and Distribution of Medical 

Gases to respond to COVID–19—were 

finalized.6 These plans of action 

established several sub-committees 

under the Voluntary Agreement, 

focusing on different aspects of each 

plan of action. 

On October 15, 2021, the sixth plan of 

action under the Voluntary 

Agreement—the Plan of Action to 

Establish a National Strategy for the 

Coordination of National Multimodal 

Healthcare Supply Chains to Respond to 

COVID–19—was finalized.7 This plan of 

action established several subcommittees under the Voluntary 

Agreement, focusing on different 

transportation categories. 

The meetings are chaired by the 

FEMA Administrator’s delegates from 

the Office of Response and Recovery 

(ORR) and Office of Policy and Program 

Analysis (OPPA), attended by the 

Attorney General’s delegates from the 

U.S. Department of Justice, and attended 

by the Chairman of the Federal Trade 

Commission’s delegates. In 

implementing the Voluntary Agreement, 

FEMA adheres to all procedural 

requirements of 50 U.S.C. 4558 and 44 

CFR part 332. 

Meeting Objectives: The objectives of 

the meetings are as follows: 

1. Convene the Sub-Committee to 

Define Requirements under the National 

Multimodal Healthcare Supply Chains 

Plan of Action to establish priorities 

related to the COVID–19 response under 

the Voluntary Agreement. 

2. Gather Sub-Committee Participants 

and Attendees to ask targeted questions 

for situational awareness. 

3. Identify pandemic-related supply 

chain issues, information gaps, and 

areas for potential additional 

discussion. 

4. Identify potential Objectives and 

Actions which correspond to SubCommittees. These will be held for 

further discussion under those SubCommittees. 

Meetings Closed to the Public: By 

default, the DPA requires meetings held 

to implement a voluntary agreement or 

plan of action be open to the public.8

However, attendance may be limited if 

the Sponsor 9 of the voluntary 

agreement finds that the matter to be 

discussed at a meeting falls within the 

purview of matters described in 5 U.S.C. 

552b(c), such as trade secrets and 

commercial or financial information. 

The Sponsor of the Voluntary 

Agreement, the FEMA Administrator, 

found that these meetings to implement 

the Voluntary Agreement involve 

matters which fall within the purview of 

matters described in 5 U.S.C. 552b(c) 

and the meetings are therefore closed to 

the public. 

Specifically, these meetings may 

require participants to disclose trade 

secrets or commercial or financial 

information that is privileged or 

confidential. Disclosure of such 

information allows for meetings to be 

closed to the public pursuant to 5 U.S.C. 

552b(c)(4). 

The success of the Voluntary 

Agreement depends wholly on the 

willing participation of the private 

sector participants. Failure to close 

these meetings to the public could 

reduce active participation by the 

signatories due to a perceived risk that 

sensitive company information could be 

released to the public. A public 

disclosure of a private sector 

participant’s information executed 

prematurely could reduce trust and 

support for the Voluntary Agreement. 

A resulting loss of support by the 

participants for the Voluntary 

Agreement would significantly hinder 

the implementation of the Agency’s 

objectives. Thus, these meeting closures 

are permitted pursuant to 5 U.S.C. 

552b(c)(9)(B). 

Deanne Criswell, 

Administrator, Federal Emergency 

Management Agency. 

[FR Doc. 2021–28596 Filed 1–5–22; 8:45 am] 

BILLING CODE 9111–19–P 

DEPARTMENT OF THE INTERIOR 

Bureau of Land Management 

[LLNMF000000.L14400000.ET0000 

LXSSG0270000 223L1109AF; NMNM– 

144042] 

Notice of Proposed Withdrawal and 

Public Meetings; San Juan County, NM 

AGENCY: Bureau of Land Management, 

Interior. 

ACTION: Notice of proposed withdrawal. 

SUMMARY: At the request of the Bureau 

of Land Management (BLM) and subject 

to valid existing rights, the Secretary of 

the Interior proposes to withdraw 

351,479.97 acres of public lands from 

location and entry under the United 

States mining laws and from leasing 

under the mineral leasing laws, but not 

disposal under the mineral materials 

laws, for a 20-year term. This notice 

segregates the lands for up to 2 years 

from location and entry under the 

United States mining laws and from 

leasing under the mineral leasing laws, 

subject to valid existing rights, initiates 

a 90-day public comment period on the 

withdrawal application, and notifies the 

public that one or more public meetings 

will be held regarding the application. 

DATES: Comments and public meeting 

requests must be received by April 6, 

2022. In-person public meetings 

regarding the withdrawal application 

will be held on February 23, 2022, from 

3:00–4:30 p.m. and 6:00–7:30 p.m. at 

San Juan College Henderson Fine Arts 

Building, 4601 College Boulevard, 

Farmington, New Mexico. All current 

guidelines issued by the Centers for 

Disease Control and Prevention and 

Department of the Interior COVID–19 

safety precautions will be strictly 

enforced. Members of the public are 

required to pre-register for the in-person 

event by using the information provided 

in the FOR FURTHER INFORMATION

CONTACT section of this notice. A virtual 

public meeting will take place on 

February 24 from 6:00–7:30 p.m. via the 

Zoom platform. To register for the 

virtual session, visit https://

blm.zoomgov.com/webinar/register/ 

WN_79HAmxoxQ-GXRVRBXl5U0w. A 

notice for public meeting(s) regarding 

the withdrawal application will be 

announced in the local newspaper and 

on the agency websites at least 30 days 

before the meeting(s). 

ADDRESSES: All comments should be 

sent to Sarah Scott, CCNHP Area 

Withdrawal, Bureau of Land 

Management Farmington Field Office, 

6251 College Blvd. Suite A, Farmington, 

NM 87402. 

A map and other information related 

to the withdrawal application are 

available at the Bureau of Land 

Management Farmington Field Office, 

6251 College Blvd., Suite A, 

Farmington, New Mexico 87402. Details 

are also available on the project 

ePlanning website: https://

eplanning.blm.gov/eplanning-ui/ 

project/2016892/510. 

FOR FURTHER INFORMATION CONTACT: 

Sarah Scott, BLM Farmington Field 


TKELLEY on DSK125TN23PROD with NOTICE